Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Conexeu SciencesCNXU -9.91%12 PB Ratio is 21.13 as of Aug. 10, 2026. GuruFocus rates CNXU with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,223 Biotechnology companies, Conexeu Sciences ranks worse than 94.52% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-10), Conexeu Sciences's share price is $7.27. Conexeu Sciences's Book Value per Share for the quarter that ended in Apr. 2026 was $0.34. Hence, Conexeu Sciences's PB Ratio of today is 21.13.
The historical rank and industry rank for Conexeu Sciences's PB Ratio or its related term are showing as below:
CNXU'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 23.82
Current: 21.38
During the past 2 years, Conexeu Sciences's highest PB Ratio was 23.82. The lowest was 0.00. And the median was 0.00.
CNXU's PB Ratio is ranked worse than 94.52% of 1223
companies
in the Biotechnology industry
Industry Median: 2.94
vs CNXU: 21.38
During the past 12 months, Conexeu Sciences's average Book Value Per Share Growth Rate was 6940.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Conexeu Sciences PB Ratio Related Terms
Conexeu Sciences PB Ratio Historical Data
* Premium members only.
The historical data trend for Conexeu Sciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Conexeu Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conexeu Sciences PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Conexeu Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Conexeu Sciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Conexeu Sciences (CNXU) has a PB Ratio of 21.13 as of Aug. 10, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Conexeu Sciences and its competitors. According to the industry distribution chart, Conexeu Sciences ranks #1156 out of 1223 companies in the Biotechnology industry, placing it in the top 94.5%.
Is Conexeu Sciences' PB Ratio too high?
Conexeu Sciences' current PB Ratio is 21.13. The Biotechnology industry median PB Ratio is 2.94. Conexeu Sciences' value of 21.13 is 618.7% above this industry median. Based on the distribution chart, Conexeu Sciences ranks #1156 out of 1223 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Conexeu Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Conexeu Sciences' PB Ratio compare to GALT and SRZN?
According to the Biotechnology industry distribution chart, Conexeu Sciences ranks #1156 out of 1223 companies for PB Ratio. This places Conexeu Sciences in the lower half of its industry. The industry median PB Ratio is 2.94. Conexeu Sciences' value of 21.13 is 618.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.94, based on 1,223 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Conexeu Sciences's current PB Ratio of 21.13 is 618.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Conexeu Sciences and its competitors. For the Biotechnology industry, the median PB Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conexeu Sciences's current PB Ratio is 21.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conexeu Sciences stock overvalued right now?
Conexeu Sciences (CNXU) has a current PB Ratio of 21.13. The current PB Ratio is 21.13 and 618.7% above the Biotechnology industry median of 2.94. Conexeu Sciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Conexeu Sciences (CNXU), the current PB Ratio is 21.13 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
12GF Score
Get the complete analysis for CNXU
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CNXU has been successfully added to your 
